Found 9 results
Filters: Author is F. Xu  [Clear All Filters]
S. - H. Wang, Xu, F., Dang, H. - X., and Yang, L., Genetic variations in the Wnt signaling pathway affect lung function in asthma patients, vol. 12, pp. 1829-1833, 2013.
F. Xu, Huang, X. H., Li, L. L., Deng, G., Cheng, H., Rong, X. F., Li, J. B., and Cheng, S. Y., Molecular cloning and characterization of GbDXS and GbGGPPS gene promoters from Ginkgo biloba, vol. 12. pp. 293-301, 2013.
Bate N and Twell D (1998). Functional architecture of a late pollen promoter: pollen-specific transcription is developmentally regulated by multiple stage-specific and co-dependent activator elements. Plant Mol. Biol. 37: 859-869. PMid:9678581   de Souza CR, Aragao FJ, Moreira EC, Costa CN, et al. (2009). Isolation and characterization of the promoter sequence of a cassava gene coding for Pt2L4, a glutamic acid-rich protein differentially expressed in storage roots. Genet. Mol. Res. 8: 334-344. PMid:19440969   Edwards D, Murray JA and Smith AG (1998). Multiple genes encoding the conserved CCAAT-box transcription factor complex are expressed in Arabidopsis. Plant Physiol. 117: 1015-1022. PMid:9662544 PMCid:34917   Gong YF, Liao ZH, Guo BH, Sun XF, et al. (2006). Molecular cloning and expression profile analysis of Ginkgo biloba DXS gene encoding 1-deoxy-D-xylulose 5-phosphate synthase, the first committed enzyme of the 2-C-methyl-D-erythritol 4-phosphate pathway. Planta Med. 72: 329-335. PMid:16557474   Kawoosa T, Singh H, Kumar A, Sharma SK, et al. (2010). Light and temperature regulated terpene biosynthesis: hepatoprotective monoterpene picroside accumulation in Picrorhiza kurrooa. Funct. Integr. Genomics 10: 393-404. PMid:20076984   Kim JH, Lee KI, Chang YJ, and Kim SU (2012). Developmental pattern of Ginkgo biloba levopimaradiene synthase (GbLPS) as probed by promoter analysis in Arabidopsis thaliana. Plant Cell Rep. 31: 1119-1127. PMid:22311479   Kim SM, Kuzuyama T, Kobayashi A, Sando T, et al. (2008). 1-Hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate reductase (IDS) is encoded by multicopy genes in gymnosperms Ginkgo biloba and Pinus taeda. Planta 227: 287-298. PMid:17763867   Liao Z, Chen M, Gong Y, Guo L, et al. (2004). A new geranylgeranyl diphosphate synthase gene from Ginkgo biloba, which intermediates the biosynthesis of the key precursor for ginkgolides. DNA Seq. 15: 153-158. PMid:15352294   Park HC, Kim ML, Kang YH, Jeon JM, et al. (2004). Pathogen- and NaCl-induced expression of the SCaM-4 promoter is mediated in part by a GT-1 box that interacts with a GT-1-like transcription factor. Plant Physiol. 135: 2150-2161. PMid:15310827 PMCid:520786   Planchais S, Perennes C, Glab N, Mironov V, et al. (2002). Characterization of cis-acting element involved in cell cycle phase-independent activation of Arath; CycB1; 1 transcription and identification of putative regulatory proteins. Plant Mol. Biol. 50: 111-127. PMid:12139003   Pufky J, Qiu Y, Rao MV, Hurban P, et al. (2003). The auxin-induced transcriptome for etiolated Arabidopsis seedlings using a structure/function approach. Funct. Integr. Genomics 3: 135-143. PMid:14648238   Redman J, Whitcraft J, Johnson C and Arias J (2002). Abiotic and biotic stress differentially stimulates as-1 element activity in Arabidopsis. Plant Cell Rep. 21: 180-185.   Reyes JC, Muro-Pastor MI and Florencio FJ (2004). The GATA family of transcription factors in Arabidopsis and rice. Plant Physiol. 134: 1718-1732. PMid:15084732 PMCid:419845   Sawai S, Shindo T, Sato S, Kaneko T, et al. (2006). Functional and structural analysis of genes encoding oxidosqualene cyclases of Lotus japonicus. Plant Sci. 170: 247-257.   Smale ST and Kadonaga JT (2003). The RNA polymerase II core promoter. Annu. Rev. Biochem. 72: 449-479. PMid:12651739   Strømgaard K and Nakanishi K (2004). Chemistry and biology of terpene trilactones from Ginkgo biloba. Angew. Chem. Int. Ed. 43: 1640-1658. PMid:15038029   Tatematsu K, Ward S, Leyser O, Kamiya Y, et al. (2005). Identification of cis-elements that regulate gene expression during initiation of axillary bud outgrowth in Arabidopsis. Plant Physiol. 138: 757-766. PMid:15908603 PMCid:1150394   van Beek TA and Montoro P (2009). Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals. J. Chromatogr. A 1216: 2002-2032. PMid:19195661   Wang Y, Liu GJ, Yan XF, Wei ZG, et al. (2011). MeJA-inducible expression of the heterologous JAZ2 promoter from Arabidopsis in Populus trichocarpa protoplasts. J. Plant Dis. Protect. 118: 69-74.   Xu F, Zhang WW, Sun NN, Li LL, et al. (2011). Effect of chlorocholine chloride on photosynthesis, soluble sugar and terpene trilactones of Ginkgo Biloba. Acta Hort. Sin. 38: 2253-2260.   Zhang ZL, Xie Z, Zou X, Casaretto J, et al. (2004). A rice WRKY gene encodes a transcriptional repressor of the gibberellin signaling pathway in aleurone cells. Plant Physiol. 134: 1500-1513. PMid:15047897 PMCid:419826
D. B. Li, Wei, X., Jiang, L. H., Wang, Y., and Xu, F., Meta-analysis of epidemiological studies of association of P53 codon 72 polymorphism with bladder cancer, vol. 9, pp. 1599-1605, 2010.
Begg CB and Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101. PMid:7786990   Chen WC, Tsai FJ, Wu JY, Wu HC, et al. (2000). Distributions of p53 codon 72 polymorphism in bladder cancer-proline form is prominent in invasive tumor. Urol. Res. 28: 293-296. PMid:11127705   Dai S, Mao C, Jiang L, Wang G, et al. (2009). p53 polymorphism and lung cancer susceptibility: a pooled analysis of 32 case-control studies. Hum. Genet. 125: 633-638. PMid:19357867   Egger M, Davey SG, Schneider M and Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634. PMid:9310563 PMCid:2127453   Hollstein M, Sidransky D, Vogelstein B and Harris CC (1991). p53 mutations in human cancers. Science 253: 49-53. PMid:1905840   Horikawa Y, Nadaoka J, Saito M, Kumazawa T, et al. (2008). Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder. Oncol. Rep. 20: 49-55. PMid:18575717   Ioannidis JP, Boffetta P, Little J, O'Brien TR, et al. (2008). Assessment of cumulative evidence on genetic associations: interim guidelines. Int. J. Epidemiol. 37: 120-132. PMid:17898028   Jemal A, Siegel R, Ward E, Hao Y, et al. (2008). Cancer statistics, 2008. CA Cancer J. Clin. 58: 71-96. PMid:18287387   Kaufman DS, Shipley WU and Feldman AS (2009). Bladder cancer. Lancet 374: 239-249.   Klug SJ, Ressing M, Koenig J, Abba MC, et al. (2009). TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol. 10: 772-784.   Koushik A, Tranah GJ, Ma J, Stampfer MJ, et al. (2006). p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int. J. Cancer 119: 1863-1868. PMid:16721787   Lee JM, Shun CT, Wu MT, Chen YY, et al. (2006). The associations of p53 overexpression with p53 codon 72 genetic polymorphism in esophageal cancer. Mutat. Res. 594: 181-188. PMid:16318864   Levine AJ (1997). p53, the cellular gatekeeper for growth and division. Cell 88: 323-331.   Lopez-Beltran A, Escudero AL, Vicioso L, Munoz E, et al. (1996). Human papillomavirus DNA as a factor determining the survival of bladder cancer patients. Br. J. Cancer 73: 124-127. PMid:8554974 PMCid:2074275   Mabrouk I, Baccouche S, El-Abed R, Mokdad-Gargouri R, et al. (2003). No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann. N. Y. Acad. Sci. 1010: 764-770. PMid:15033824   Maloney KE, Wiener JS and Walther PJ (1994). Oncogenic human papillomaviruses are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. J. Urol. 151: 360-364. PMid:8283525   Matakidou A, Eisen T and Houlston RS (2003). TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18: 377-385. PMid:12840112   Murgel de Castro Santos LE, Trindade Guilhen AC, Alves de AR, Garcia SL, et al. (2009). The role of TP53 Pro47Ser and Arg72Pro single nucleotide polymorphisms in the susceptibility to bladder cancer. Urol. Oncol. (in press). DOI: 10.1016/j.urolonc.2009.03.026.   Rubben H, Lutzeyer W, Fischer N, Deutz F, et al. (1988). Natural history and treatment of low and high risk superficial bladder tumors. J. Urol. 139: 283-285. PMid:3339726   Simoneau M, LaRue H and Fradet Y (1999). Low frequency of human papillomavirus infection in initial papillary bladder tumors. Urol. Res. 27: 180-184. PMid:10422819   Soulitzis N, Sourvinos G, Dokianakis DN and Spandidos DA (2002). p53 codon 72 polymorphism and its association with bladder cancer. Cancer Lett. 179: 175-183.   Sousa H, Santos AM, Pinto D and Medeiros R (2007). Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int. J. Mol. Med. 20: 731-741. PMid:17912468   Tommiska J, Eerola H, Heinonen M, Salonen L, et al. (2005). Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin. Cancer Res. 11: 5098-5103. PMid:16033823   Toruner GA, Ucar A, Tez M, Cetinkaya M, et al. (2001). p53 codon 72 polymorphism in bladder cancer - no evidence of association with increased risk or invasiveness. Urol. Res. 29: 393-395. PMid:11828992   Zhou Y, Li N, Zhuang W, Liu GJ, et al. (2007). p53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int. J. Cancer 121: 1481-1486. PMid:17546594